Construction of novel g-C3N4 coupled efficient Bi2O3 nanoparticles for improved Z-scheme photocatalytic removal of environmental wastewater contaminant: Insight mechanism

Recently, the major environmental pollution produced by the release of wastewater in liquid type is one of the most extensive forms of foremost pollution in water ecosystems. In this article, the Bi₂O₃/g-C₃N₄ nanocomposite with a direct Z-scheme was effectively obtained by a facile hydrothermal system. The crystal structures, surface morphology, chemical composition, and the optical belongings of the as-obtained composite catalysts were examined by Power XRD, FT-IR spectra, High-resolution XPS spectra, FE-SEM images with EDX spectra, High-resolution TEM images, UV-Vis DRS, and PL spectra respectively. Furthermore, the photocatalytic performance was assessed by the degradation of aqueous Rhodamine B (Rh B) dye under visible-light exposure. The Bi₂O₃/g-C₃N₄ composite photocatalysts (PCs) showed the maximum photo-degradation efficiency through a rate constant value of 0.0149 min^-1, which is 4.9 and 5.3 folds superior to Bi₂O₃, and GCN, respectively. The better GBO2 nanocomposite PCs showed a superior photocatalytic degradation performance (>82%) of aqueous Rh B dye after five successive recycles. Moreover, based on these outcomes of the radical scavenging test, a direct and effective Z-scheme photocatalytic charger transfer mechanism was also projected. Finally, the reusability of the as-obtained Bi₂O₃/g-C₃N₄ nanocomposite has better stability and reusability, which was a favourable applicant for wastewater handling.

A systematic review of complications following selective dorsal rhizotomy in cerebral palsy

PURPOSE

The literature lacks a concise overview of complications secondary to selective dorsal rhizotomy (SDR). The aim of this study was to systematically review the literature regarding post-SDR complications, and to present them concisely.

METHODS

The protocol of the review was registered on Open Science Framework. Studies on SDR in cerebral palsy were included. The studies to be included used SDR for management of spasticity in patients with cerebral palsy. The long-term complications of SDR mentioned in the articles were inventoried.

RESULTS

Thirty studies were included for qualitative review. Twenty-one types of complication were identified. Structural complications were the commonest: scoliosis (214/1,043, 20.5%), hyperlordosis (101/552, 18.2%), spondylolysis (55/574, 9.5%) and kyphosis (67/797, 8.4%). Neurological complications comprised constipation (70/485, 14.4%), hip subluxation (3/29, 10.3%), spastic syndrome (4/47, 8.5%), sensory changes (106/1290, 8.2%) and urinary incontinence (61/1013, 6%).

CONCLUSION

This review should help surgeons and parents alike to know about the potential complications of SDR. Complications may affect quality of life and should be weighed. Although the majority of these complications were managed conservatively, there would still be a physical, psychological and financial burden which should be taken into account. Screening should be continued vigorously throughout skeletal growth and at reduced frequency thereafter, for timely intervention in case of structural complications.

Measurement of the ν_{e}-Nucleus Charged-Current Double-Differential Cross Section at ⟨E_{ν}⟩=2.4 GeV Using NOvA

The inclusive electron neutrino charged-current cross section is measured in the NOvA near detector using 8.02×10^{20} protons-on-target in the NuMI beam. The sample of GeV electron neutrino interactions is the largest analyzed to date and is limited by ≃17% systematic rather than the ≃7.4% statistical uncertainties. The double-differential cross section in final-state electron energy and angle is presented for the first time, together with the single-differential dependence on Q^{2} (squared four-momentum transfer) and energy, in the range 1  GeV≤E_{ν}<6  GeV. Detailed comparisons are made to the predictions of the GENIE, GiBUU, NEUT, and NuWro neutrino event generators. The data do not strongly favor a model over the others consistently across all three cross sections measured, though some models have especially good or poor agreement in the single differential cross section vs Q^{2}.

Facile construction of cost-effective zinc-aluminium polymeric framework for efficient removal of selective both drug and dye from an aqueous medium

A novel aluminium (Al) and its active alloys are extensively been used in nearly all areas owing to their cost-effectiveness. But when it is subjected to an aqueous medium, gets corroded through a chemical response. In this paper, a novel framework was fabricated by copolymer coating over on Al and loaded with zinc via electro polymerization and electrodeposition method ([EDA- OPDA]Al@Zn). The as-fabricated composite has emerged for the sorption of Methylene Blue (MB) aqueous dye and Paracetomal drug (PAR). The as-fabricated composite framework has been categorized via IR spectra, FE-SEM images, and EDX spectra. The sorption progression was optimized for numerous prompting features like pH, contact time and impact of dosage. Based on kinetics data, the growth in QE value by an enhancement in temperature for adsorption and the higher r values shows the adsorption progression is a pseudo-second-order model. The thermodynamic constraints specify that the field of adsorbate is impulsive and typical endothermic process. Instead, the corrosion resistance of a composite in the 3.5% of NaCl. Solution was explored via EIS spectra and potentio-dynamic polarization. Depending on the observed features, it indicates that the [EDA-OPDA]Al@Zn framework provided fantastic corrosion resistance. So it is obvious that the as-synthesized framework is of multitasking, that it could be successfully performed for the exclusion of MB aqueous dye and PAR drug from the aqueous medium and it also withstands effectively in this corrosive medium.

Incidence and risk factors for major bleeding events in atrial fibrillation patients on direct oral anticoagulant therapy: data from the National Patient-Centered Clinical Research Network

Background

Direct oral anticoagulation (DOACs) prevent stroke in patients with atrial fibrillation (AF) and have a superior safety profile compared with vitamin K antagonists (VKA). Yet, better definition of incidence and risk factors for major bleeding associated with DOACs in clinical practice may be important given emerging stroke prevention technologies, both pharmacologic and nonpharmacologic.

Purpose

To describe the incidence of and risk factors for major bleeding in individuals with AF on DOAC therapy.

Methods

We reviewed electronic health record data for two patient cohorts with AF prescribed DOACs: (1) Duke University Health System (DUHS) (2010–2018) and (2) Sites within the Patient-Centered Clinical Research Network (PCORnet) (2015–2019) which had ≥6 years assimilated data from both inpatient and outpatient encounters (7 sites). In each cohort, we assessed the 5-year incidence of major bleeding events defined as hospitalization for intracranial hemorrhage, or hospitalization for gastro-intestinal bleeding or procedure to control bleeding accompanied by transfusion within ±7 days or death within 30 days. Multivariable Fine-Gray proportional hazards modeling in each cohort was performed to evaluate independent risk factors for major bleeding on DOAC therapy.

Results

The cohorts included 10,625 patients (DUHS) and 58,321 patients (PCORnet) with AF. Major bleeding events occurred within 5 years of diagnosis in 639 (7.9%) of DUHS patients and 2568 (6.6%) of PCORnet patients (Table 1). The DUHS model predicted time to first major bleeding event with a C-index of 0.756 (95% CI 0.737, 0.775) and the PCORNet model had a c-index of 0.745 (0.736, 0.755) (Table 2). Independent factors associated with major bleeding consistent across both models (p&lt;0.001 in PCORnet for all unless noted) were higher CHA2DS2-VASc scores, lower eGFR, anemia (HR per 1-point increase in hemoglobin up to 12 g/dL 0.79 [0.76, 0.82]), prior major bleeding (HR 2.70 [2.22, 3.30]), cancer (HR 1.23 [1.12, 1.36]), recent cardiac surgery (HR 0.70 [0.51, 0.97]; p=0.030), alcohol use (HR 1.56 [1.29, 1.88]), aspirin use (HR 1.44 [1.32, 1.57]), and selective serotonin reuptake inhibitor use (HR 1.30 [1.19, 1.42]).

Conclusions

Across a large and geographically diverse contemporary population, risk of bleeding on DOAC for stroke prevention in AF remains a frequent and important clinical problem. There is an unmet need for stroke prevention therapies with improved safety profiles. We identified risk factors for major bleeding events on DOAC therapy, some of which are not represented in traditional risk scores, which may inform shared decision making for stroke prevention.

Funding Acknowledgement

Type of funding sources: Private company. Main funding source(s): Bayer Pharmaceuticals

Search for Active-Sterile Antineutrino Mixing Using Neutral-Current Interactions with the NOvA Experiment

This Letter reports results from the first long-baseline search for sterile antineutrinos mixing in an accelerator-based antineutrino-dominated beam. The rate of neutral-current interactions in the two NOvA detectors, at distances of 1 and 810 km from the beam source, is analyzed using an exposure of 12.51×10^{20} protons-on-target from the NuMI beam at Fermilab running in antineutrino mode. A total of 121 of neutral-current candidates are observed at the far detector, compared to a prediction of 122±11(stat.)±15(syst.) assuming mixing only between three active flavors. No evidence for ν[over ¯]_{μ}→ν[over ¯]_{s} oscillation is observed. Interpreting this result within a 3+1 model, constraints are placed on the mixing angles θ_{24}<25° and θ_{34}<32° at the 90% C.L. for 0.05  eV^{2}≤Δm_{41}^{2}≤0.5  eV^{2}, the range of mass splittings that produces no significant oscillations at the near detector. These are the first 3+1 confidence limits set using long-baseline accelerator antineutrinos.

P39 Cross sectional survey of medical student volunteering and education during the coronavirus pandemic in the United Kingdom

Introduction

COVID-19 led to global disruption of healthcare and many students volunteered to provide clinical support. Volunteering to work was a unique medical education opportunity; however, it is unknown whether this was a positive learning experience.

Methods

The COVID Ready 2 study is a national cross-sectional study of all medical students at UK medical schools. We will compare opinions of those who did and did not volunteer to determine the educational benefit and issues they faced. We will use thematic analysis to identify themes in qualitative responses, in addition to quantitative analysis.

Results

The primary objective is to explore the effect of volunteering during the pandemic on medical education in comparison to those who did not volunteer. Our secondary objectives are to identify: whether students would be willing to assume similar roles in a non-pandemic setting; if students found the experience more or less beneficial than traditional hospital placements and reasons for this; what the perceived benefits and disadvantages of volunteering were; the difference in perceived preparedness between students who did and did not volunteer for foundation training year one and the next academic year; training received by volunteers; and to explore issues associated with volunteering, including safety issues and issues with role and competence.

Conclusions

We anticipate this study will help identify volunteer structures that have been beneficial for students, so that similar infrastructures can be used in the future; and help determine whether formal voluntary roles should be introduced into the non-pandemic medical curriculum.

Saphenous vein graft aneurysm - Unusual cause of hemoptysis: A case report and review of literature

Hemoptysis due to saphenous venous graft (SVG) aneurysm is an extremely rare condition and published literature has described the role of conservative management, surgical resection, and covered stent. Here, we report a successful placement of a covered stent for SVG aneurysm in a 56-year-old male who presented with hemoptysis. He was a known diabetic and had undergone a coronary artery bypass grafting 5 years ago. Computed tomography (CT) chest and fiberoptic bronchoscopy performed in another local hospital had revealed blood in the left lingula with spillover into the left lung parenchyma. Hence, he had received empirical anti-tuberculosis medication for 2 months without any improvement. He was referred to our hospital for further management of hemoptysis. Multidetector CT (MDCT) angiography of the chest covering coronaries performed at our hospital revealed SVG aneurysm that was managed with covered stent placement.

Therapeutic potential of benfotiamine and its molecular targets

OBJECTIVE

The water-soluble vitamin, thiamine forms an important part of the diet because of its role in the energy metabolism. The protective effects of thiamine against diabetic vascular complications have been well documented. However, slower absorption and reduced bioavailability is a major limiting factor for its clinical use. To overcome this issue, lipid-soluble derivatives of thiamine (allithiamines) was developed. Among the many synthetic lipophilic derivatives of thiamine, benfotiamine (BFT) is regarded as the first choice based on its safety and clinical efficacy data. BFT facilitates the action of thiamine diphosphate, a cofactor for the enzyme transketolase. The activation of transketolase enzyme accelerates the precursors of advanced glycation end products (AGEs) towards the pentose phosphate pathway thereby reducing the production of AGEs. The reduction in AGEs subsequently decreases metabolic stress which benefits vascular complications seen in diabetes. The effects of BFT on the AGE-dependent pathway is well established. However, several studies have shown that BFT also modulates pathways other than AGE such as arachidonic acid (AA), nuclear transcription Factor κB (NF-κβ), protein kinase B, mitogen-activated protein kinases (MAPK) and vascular endothelial growth factor receptor 2 (VEGFR2) signaling pathways. In the present review, we have comprehensively reviewed all the molecular targets modulated by BFT to provide mechanistic perspective to highlight its pleiotropic effects.

First measurement of neutrino oscillation parameters using neutrinos and antineutrinos by NOvA

The NOvA experiment has seen a 4.4σ signal of ν[over ¯]_{e} appearance in a 2 GeV ν[over ¯]_{μ} beam at a distance of 810 km. Using 12.33×10^{20} protons on target delivered to the Fermilab NuMI neutrino beamline, the experiment recorded 27 ν[over ¯]_{μ}→ν[over ¯]_{e} candidates with a background of 10.3 and 102 ν[over ¯]_{μ}→ν[over ¯]_{μ} candidates. This new antineutrino data are combined with neutrino data to measure the parameters |Δm_{32}^{2}|=2.48_{-0.06}^{+0.11}×10^{-3}  eV^{2}/c^{4} and sin^{2}θ_{23} in the ranges from (0.53-0.60) and (0.45-0.48) in the normal neutrino mass hierarchy. The data exclude most values near δ_{CP}=π/2 for the inverted mass hierarchy by more than 3σ and favor the normal neutrino mass hierarchy by 1.9σ and θ_{23} values in the upper octant by 1.6σ.

The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey

BACKGROUND

Patients with postural tachycardia syndrome (POTS) experience chronic symptoms of orthostatic intolerance. There are minimal data detailing the demographics, clinical features and clinical course of this condition. This online, community-based survey highlights patients' experience with POTS. It consists of the largest sample of POTS patients reported to date.

OBJECTIVES

To describe the demographics, past medical history, medications, treatments and diagnostic journey for patients living with POTS.

METHODS

Postural tachycardia syndrome patients completed an online, community-based, cross-sectional survey. Participants were excluded if they had not received a diagnosis of POTS from a physician. The questions focused on the patient experience and journey, rather than physiological responses.

RESULTS

The final analysis included 4835 participants. POTS predominantly affects white (93%) females (94%) of childbearing age, with approximately half developing symptoms in adolescence (mode 14 years). POTS is a chronic multisystem disorder involving a broad array of symptoms, with many patients diagnosed with comorbidities in addition to POTS. POTS patients often experience lengthy delays [median (interquartile range) 24 (6-72) months] and misdiagnosis, but the diagnostic delay is improving. POTS patients can present with a myriad of symptoms most commonly including lightheadedness (99%), tachycardia (97%), presyncope (94%), headache (94%) and difficulty concentrating (94%).

CONCLUSIONS

These data provide important insights into the background, clinical features and diagnostic journey of patients suffering from POTS. These data should serve as an essential step for moving forward with future studies aimed at early and accurate diagnoses of these patients leading to appropriate treatments for their symptoms.

Tunable physicochemical and free volume characteristics of novel terpolymer–poly(vinyl alcohol)-grafted membranes for direct methanol fuel cells

Here, we describe a facile and scalable approach to fabricate novel ABC-type terpolymer-based proton conducting membranes (PCMs) and elucidate the benefits of utilizing terpolymer composite membrane polymer materials as electrolytes for direct methanol fuel cells (DMFC).

Gentamicin-loaded ceramic-biopolymer dual layer coatings on the Ti with improved bioactive and corrosion resistance properties for orthopedic applications

In orthopedic surgery, osteomyelitis (bone infection) is one of the most serious complications in the last few decades and the resident drug delivery is the key strategy to overcome this issue. Combination of bioactive materials with antibiotics is broadly developed for the handling of osteomyelitis which plays a dual role as bone cell growth and as local drug delivery systems for antibiotic delivery. TiO₂-SiO₂ mixtures were fabricated on Ti alloy by anodization method. Chitosan-Lysine (CS-LY) biopolymers were coated on composites by electrodeposition method and followed by gentamicin sulfate (GS) which was loaded as a model drug. The layers were characterized by AT-FTIR, XRD, FE-SEM and EDX methods. The mechanical, anticorrosion, antimicrobial effects and biocompatibility of the glazes were considered. In addition, drug loading, continued and prolonged liberation behaviors of GS from the fabricated coating were studied. The apatite development ability and cell viability are outstanding for CS-LY-3 coated composites. In vitro cell experimentations indicate that osteoblasts show good adhesion and high growth rates for CS-LY-3 coated TiO₂-SiO₂ composite substrate. In conclusion, the surface modification of TiO₂-SiO₂/CS-LY-3 coated Ti alloy could be used as a carrier for GS, not only to eradicate the osteomyelitis caused by Gram-negative and Gram-positive bacteria, but also to repair the bone defect initiated by the infection owing to the tunable nanocomposite degradation.

Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid

Pyrazinamide (PYZ)-an essential component of primary drug regimen used for the treatment and management of multidrug resistant or latent tuberculosis-is well known for its hepatoxicity. However, the mechanism of PYZ-induced hepatotoxicity is still unknown to researchers. Studies have shown that the drug is metabolized in the liver to pyrazinoic acid (PA) and 5-hydroxy pyrazinoic acid (5-OHPA) which individually may cause different degrees of hepatotoxicity. To evaluate this hypothesis, PYZ, PA, and 5-OHPA were administered to albino Wistar rats orally (respectively, at 250, 125, and 125 mg kg^-1 for 28 days). Compared to normal rats, PYZ and its metabolic products decreased the weights of dosed rats and induced liver injury and a status of oxidative stress as assessed by combined histopathological and biochemical analysis. Compared to normal controls, the biochemical and morphological changes were more aberrant in PA- and 5-OHPA-dosed rats with respect to those dosed with PYZ. Finally, the serum metabolic profiles of rats dosed with PYZ, PA, and 5-OHPA were measured and compared with those of normal control rats. With respect to normal control rats, the rats dosed with PYZ and 5-OHPA showed most aberrant metabolic perturbations in their sera as compared to those dosed with PA. Altogether, the study suggests that PYZ-induced hepatotoxicity might be associated with its metabolized products, where 5-OHPA contributes to a higher degree in its overall toxicity than PA.

Fabrication and characterization of poly(vinyl alcohol)-TiO2 nanocomposite films for orthopedic applications

Poly(vinyl alcohol) (PVA) is reinforced with TiO2 nanoparticles in order to enhance thermo-mechanical stabilities, surface characteristics and osteoblastic cell adhesion. PVA-TiO2 nanocomposite films with desirable mechanical, thermal and biocompatible properties are fabricated through solution casting method followed by de-hydrothermal cross-linking treatment. The composition of TiO2 nanoparticles was standardized to achieve mechanically stable nanocomposite films, based on tensile strength measurements composition of TiO2 is determined as optimal at 3wt%. PVA-TiO2 nanocomposite films were characterized by Scanning electron microscopy, Energy dispersive spectroscopy, Atomic force microscopy, Ultra violet and Fourier transform infrared spectroscopic techniques. Elemental mapping studies substantiate incorporation of TiO2 nanoparticles within the PVA matrix. Dimensional stability evaluated by soaking films in SBF for 24h insinuates the role of TiO2 in the direction of controlling degree of swelling. In-vitro bioactivity test and cell adhesion results also predict that presence of TiO2 is advantageous to enhance apatite growth and promote cell-substrate interaction. SEM studies illustrate improved surface morphology of PVA-TiO2 nanocomposite film with homogenously distributed TiO2 nanoparticles, which help to enhance thermo-mechanical behavior. TiO2 nanoparticles construct cell-adhesive hydrophilic nano-domains that act as potential cell adhesion sites and promotes osteointegration. Bio compatibility studies proved that thermally cross-linked PVA is non-toxic in relation to PVA cross-linked with glutaraldehyde. Cytotoxicity and cell adhesion of nanocomposite films evaluated through cell viability (MMT) assay and crystal violet staining revealed that PVA-3wt% TiO2nanocomposite could act as an excellent composite and hence suitable to be used in bone implant applications.

Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug

In this work, β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated iron oxide nanoparticles (Fe3O4-β-CD-PEG-PEI) were developed as drug carriers for drug delivery applications. The 5- Fluorouracil (5-FU) was chosen as model drug molecule. The developed nanoparticles (Fe3O4-β-CD-PEG-PEI) were characterized by various techniques such as Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), Scanning electron microscopy (SEM), transmission electron microscopy (TEM) and vibrating sample magnetometry (VSM). The average particles size range of 5-FU loaded Fe3O4-β-CD, Fe3O4-β-CD-PEG and Fe3O4-β-CD-PEG-PEI nanoparticles were from 151 to 300nm and zeta potential value of nanoparticles were from -43mV to -20mV as measured using Malvern Zetasizer. Finally, encapsulation efficiency (EE), loading capacity (LC) and in-vitro drug release performance of 5-FU drug loaded Fe3O4-β-CD, Fe3O4-β-CD-PEG and Fe3O4-β-CD-PEG-PEI nanoparticles was evaluated by UV-vis spectroscopy. In-vitro cytotoxicity tests investigated by MTT assay indicate that 5-FU loaded Fe3O4-β-CD-PEG-PEI nanoparticles were toxic to cancer cells and non-toxic to normal cells. The in-vitro release behavior of 5-FU from drug (5-FU) loaded Fe3O4-β-CD-PEG-PEI composite at different pH values and temperature was studied. It was found that 5-FU was released faster in pH 6.8 than in the acidic mediums (pH 1.2), and the released quantity was higher. Therefore, the newly prepared Fe3O4-β-CD-PEG-PEI carrier exhibits a promising potential capability for anticancer drug delivery in tumor therapy.

Bio-functionalized hybrid nanocomposite membranes for direct methanol fuel cells

Featured methanol-blocking characteristics of nanocomposite membrane.

The synthesis, characterization, removal of toxic metal ions and in vitro biological applications of a sulfanilamide–salicylic acid–formaldehyde terpolymer

SASF terpolymer possess great applications for removal of heavy metal ions from environmental and industrial wastes.

Phenotyping airways disease: an A to E approach

The airway diseases asthma and chronic obstructive pulmonary disease (COPD) are heterogeneous conditions with overlapping pathophysiological and clinical features. It has previously been proposed that this heterogeneity may be characterized in terms of five relatively independent domains labelled from A to E, namely airway hyperresponsiveness (AHR), bronchitis, cough reflex hypersensitivity, damage to the airways and surrounding lung parenchyma, and extrapulmonary factors. Airway hyperresponsiveness occurs in both asthma and COPD, accounting for variable day to day symptoms, although the mechanisms most likely differ between the two conditions. Bronchitis, or airway inflammation, may be predominantly eosinophilic or neutrophilic, with different treatments required for each. Cough reflex hypersensitivity is thought to underlie the chronic dry cough out of proportion to other symptoms that can occur in association with airways disease. Structural changes associated with airway disease (damage) include bronchial wall thickening, airway smooth muscle hypertrophy, bronchiectasis and emphysema. Finally, a variety of extrapulmonary factors may impact upon airway disease, including rhinosinusitis, gastroesophageal reflux disease, obesity and dysfunctional breathing. This article discusses the A to E concept in detail and describes how this framework may be used to assess and treat patients with airway diseases in the clinic.

Abstract P3-06-30: Predictors of Pathologic Complete Response to Chemotherapy and Antiangiotherapy in Breast Cancer

Vascular endothelial growth factor (VEGF) is a central mediator of angiogenesis in breast cancer. We have conducted a clinical trial using bevacizumab (B) in breast cancer in the neoadjuvant setting and showed improved pathologic complete response (pCR) when B was added to chemotherapy (CT). 41% of patients (Pts) who received B+CT achieved pCR. Blood and tumor samples were collected at baseline and serially on treatment from 39 patients who participated in the study. The correlative study was approved by the IRB and consent forms were obtained at the time of enrollment. Since patients do not equally benefit from B, it has become necessary to define the profile of patients who will benefit and those who are more likely to have major side effects from the drug. This study was conducted to evaluate for the presence of specific SNPs and CNV in the germ line and a serum protein profile that might be predictive of pCR in the neoadjuvant setting in breast cancer patients receiving B and CT.

Methods: To test for the presence of functional germ line SNPs and CNVs that may influence pCR, DNA was extracted from buffy coats of study participants and SNPs/CNVs were determined using Illumina technology. To test the hypothesis that individuals who achieved pCR were those with differential expression of selected proteins in their blood, custom multiplex was performed for the following serum proteins: ANG-1, ANG-2, bFGF, IL-1a, MMP-9, PDGF-BB, PECAM-1, Tie-2, VEGF, and VEGFR2.

Statistical test: The association between genotype and CNV of each SNP vs. pCR status were analyzed using Cochran-Armitage Trend Test. Differences in serum protein levels between pCR and non-pCR groups were examined by Wilcoxon rank sum test. Significance of association was evaluated in two settings of α (i) α=0.05 (ii) α=0.00001.

Results: Genotype and CNV vs. pCR (n = 38). In genotype vs. pCR status by SNPs tests, 131618 (∼13%) SNPs with allele frequency &lt;0.05 were excluded from the analysis. In CNV vs. pCR status by SNPs tests, only 46891 (4.6%) SNPs were analyzed. Many SNPs were excluded because there was no variability in their CNVs. Though no SNPs found significant at genome-wide level of significance (&lt;10−5), a number of SNPs were significant at the level of individual tests in these comparisons. Four SNPs at a p value &lt; 0.0001 were identified. A SNP in the promoter region of H(+)-myo-inositol co-transporter gene was most frequently associated with pCR.

Analysis of baseline serum protein data (n = 34). The results of pCR vs. serum protein data analysis suggest that there is a statistically significant difference between the concentration of bFGF and Tie-2 in the pCR group (higher baseline values) and those in the non-pCR group (p-values &lt;0.05). The difference of concentrations of VEGF trended toward significance between these two groups.

Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischaemia and viability assessment

Coronary artery disease has an important impact on the morbidity and mortality statistics and health economics worldwide. Diagnosis of coronary artery disease is important in risk stratification and guides further management. Invasive coronary angiography is the traditional method of imaging the coronary arteries and remains the gold standard. It detects luminal stenosis but provides little information about the vessel wall or plaques. Besides, not all anatomical lesions are functionally significant. This has lent itself to a wide variety of imaging techniques to identify and assess a flow-limiting stenosis. The approach to diagnosis of coronary artery disease is broadly based on anatomical and functional imaging. Coronary CT and MRI of coronary arteries provide an anatomical assessment of coronary stenosis. Coronary calcium score and coronary CT assess subclinical atherosclerosis by assessing the atherosclerotic plaque burden. The haemodynamic significance of a coronary artery stenosis can be assessed by stress radioisotope studies, stress echocardiography and stress MRI. The more recent literature also focuses on plaque assessment and identification of plaques that are likely to give rise to an acute coronary syndrome. There is an explosion of literature on the merits and limitations of the different imaging modalities. This review article will provide an overview of all the imaging modalities in the diagnosis of coronary artery disease.

Pulmonary complications in the non-HIV immunocompromised patient

The incidence of non-HIV immunocompromised patients is increasing. This is primarily due to improved immunosuppressive regimes for autoimmune diseases and also increases in stem cell transplantation. Pulmonary complications are a major cause of morbidity and mortality in these patients. Imaging is frequently used to assess these complications and to streamline therapies, as microbiological and/or pathological diagnosis can often be difficult, invasive, or protracted. This review provides the reader with a structured approach to interpret the imaging findings and differentiate between different infective and non-infective complications in these patients.

Pharmacological screening of Coriandrum sativum Linn. for hepatoprotective activity

Objective:

Coriandrum sativum (Linn.), a glabrous, aromatic, herbaceous annual plant, is well known for its use in jaundice. Essential oil, flavonoids, fatty acids, and sterols have been isolated from different parts of C. sativum. The plant has a very effective antioxidant profile showing 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, lipoxygenase inhibition, phospholipid peroxidation inhibition, iron chelating activity, hydroxyl radical scavenging activity, superoxide dismutation, glutathione reduction and antilipid peroxidation due to its high total phenolic content with the presence of constituents like pyrogallol, caffeic acid, glycitin, etc.

Materials and Methods:

This study was aimed at investigating the hepatoprotective activity of C. sativum against carbon tetrachloride (CCl4), with estimation of serum serum glutamyl oxaloacetic acid transaminase (SGOT), serum glutamyl pyruvate transaminase (SGPT), alkaine phosphatase (ALP) and bilirubin, and with liver histopathology.

Results:

Ethanolic extract was found to be rich in alkaloids, phenolic compounds and flavonoids, and high performance liquid chromatography (HPLC) fingerprinting showed the presence of iso-quercetin and quercetin. C. sativum signifies hepatoprotection by reducing the liver weight, activities of SGOT, SGPT, and ALP, and direct bilirubin of CCl₄ intoxicated animals. Administration of C. sativum extract at 300 mg/kg dose resulted in disappearance of fatty deposit, ballooning degeneration and necrosis, indicating antihepatotoxic activity.

Conclusion:

The results of this study have led to the conclusion that ethanolic extract of C. sativum possesses hepatoprotective activity which may be due to the antioxidant potential of phenolic compounds.